Novo Nordisk wins US approval for higher-dose Wegovy
Novo Nordisk (NVO) (NONOF) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved a new 7.2 mg version of its blockbuster obesity therapy Wegovy as a treatment to lower extra body weight and maintain weight reduction in the long...
Seeking Alpha